Longer-term safety and efficacy of baricitinib for atopic dermatitis in pediatric patients 2 to <18 years old: a randomized clinical trial of extended treatment to 3.6 years

Files

Wollenberg, A.

Ikeda, Masanori

Chu, Chia-Yu

Eichenfield, L.F.

Seyger, M.M.B. Marieke

Prakash, Apurva

Pontes, Marco

Paller, Amy S.